Emergent Biosolutions Inc

Research Emergent Biosolutions Inc (EBS) on Bullrun: market cap USD 436.50M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEBS
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 436.50M
• Financial periodFY2025
• RevenueUSD 742.90M
• Revenue growth-28.8%
• Net incomeUSD 52.60M
• Free cash flowUSD 156.80M
• Gross margin56.1%

Valuation Snapshot

latest market cap is USD 436.50M.

About Emergent Biosolutions Inc

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax;

Frequently asked questions

What is Emergent Biosolutions Inc's market cap?

Emergent Biosolutions Inc's market capitalization is USD 436.50M.

What does Emergent Biosolutions Inc do?

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally.